|
[Related PubMed/MEDLINE] Total Number of Papers: 13
|
|
|
[Display Entries]
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: pOCs |
Long Form |
: preosteoclasts |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
Suppression of osteoclast multinucleation via a posttranscriptional regulation-based spatiotemporally selective delivery system. |
POCMs |
2 |
2021 |
Bone-targeted pH-responsive cerium nanoparticles for anabolic therapy in osteoporosis. |
CNS, mOCs, PDGF-BB |
3 |
2021 |
Light rare earth elements hinder bone development via inhibiting type H vessels formation in mice. |
BMMs, LREEs |
4 |
2020 |
GDNF secreted by pre-osteoclasts induces migration of bone marrow mesenchymal stem cells and stimulates osteogenesis. |
BMMSCs, GDNF, POC-CM |
5 |
2019 |
Vitamin B5 inhibit RANKL induced osteoclastogenesis and ovariectomy induced osteoporosis by scavenging ROS generation. |
FOXO1, FoxO2, Nrf2, PI3K-Akt, TRAP |
6 |
2017 |
Pmepa1 induced by RANKL-p38 MAPK pathway has a novel role in osteoclastogenesis. |
--- |
7 |
2009 |
Enhanced inhibitory effects of a novel CpG motif on osteoclast differentiation via TREM-2 down-regulation. |
PBMCs, TLR9 |
8 |
2008 |
The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. |
--- |
9 |
2007 |
The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-beta-induced inhibitory signaling. |
BMMs, IFNs, RANKL, siRNA |
10 |
2005 |
[Differentiation of osteoclasts]. |
OCs, OPG, RANKL |
11 |
2004 |
Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha). |
M-CSF, RANKL, TNF-alpha |
12 |
2004 |
Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. |
MD, NF-kappaB, OCL, TRAP |
13 |
2002 |
Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin. |
M-CSF, OCs, OPG, RANKL, RB, TRAP |
|